Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03316586
Brief Title: A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer

First Submitted : October 18, 2017
First Submitted that Met QC Criteria : October 18, 2017
First Posted : October 20, 2017

Last Update Submitted that Met QC Criteria : February 1, 2021
Last Update Posted : February 2, 2021